Leem in the news

The Leem, a pharmaceutical industry association, urges presidential candidates to prioritize health, proposing ten measures to improve patient access to care and innovative treatments, strengthen health sovereignty, and ensure the sustainability of the health system in France.

The Snitem opposes the medical device tax while Leem finds encouraging signals in the social security financing bill.

An agreement was signed between the CEPS and the pharmaceutical industry on September 28, 2026, to balance access to innovative medicines with efficiency measures in France.

Pharmaceutical companies, including Leem, cautiously welcome a new framework agreement with regulators, highlighting both benefits for innovation and significant industry contributions to healthcare savings.

The CEPS presented a new framework agreement proposal to pharmaceutical industry unions for signature by September 28, with the current agreement expiring on September 30.

A new framework agreement in France introduces a "pay more at the beginning, less at the end" strategy for medicines, aiming for economic predictability for innovative drugs while ensuring financial sustainability.

Leem identifies critical issues in the French healthcare sector, including slow access to new drugs and declining clinical research, proposing a 10-point plan to revitalize it by treating medication as an investment and modernizing health policies.

Leem, the French pharmaceutical industry association, is pushing for pharmaceuticals to be a strategic focus in the 2027 presidential election, advocating for reforms in reimbursement, innovation funding, and increased recognition of industry contributions.

Leem launched an online platform to analyze presidential candidates' health proposals and offer its own recommendations for the 2027 election, highlighting challenges in the French healthcare system and proposing solutions.

Leem presented its platform for the 2027 presidential election, focusing on broader perspectives for the pharmaceutical industry.

Pharmaceutical laboratories are advocating for healthcare to become a central issue in the French presidential campaign due to the system's decline.

Leem positions medication as a strategic national issue, advocating for health system reforms including multi-year planning, innovation financing, and a reconsideration of drug reimbursement and investment policies in France.

Leem, a pharmaceutical industry association, released ten proposals for the 2027 presidential election to re-establish France's strategic role in health innovation.

Leem unveiled 10 proposals for the 2027 French presidential election, advocating for patient-centric healthcare and a modernized health policy.

Leem, the pharmaceutical industry union, presented ten proposals for the presidential election focusing on modernizing health policy, sovereignty, and funding.

The Leem outlines its proposals for the 2027 presidential election, focusing on modernizing health policy, accelerating biosimilar substitution, optimizing drug management, addressing shortages, and shifting care to community settings.

The Leem, representing pharmaceutical industries, presented ten proposals to presidential candidates for the 2027 election, focusing on health priorities like research and drug availability, avoiding social security financing debates.

The French pharmaceutical industry is urging authorities to implement urgent reforms to improve its attractiveness, boost research, and enhance patient access to innovative treatments amidst declining competitiveness.

A national consultation involving citizens and healthcare professionals in France identified significant challenges within the healthcare system, including slow access to medicines and organizational inefficiencies, leading to proposals for improved access, research, and patient education.

Accenture, Undiz, Generix, Duval, and Leem announce new leadership appointments across various departments and regions.